메뉴 건너뛰기
Medecine/Sciences
Volumn 21, Issue 2, 2005, Pages 187-189
DSMB. 2. The importance of an efficient DSMB: Some examples of high-risk clinical trials;Les DSMB. 2. De l'importance d'un DSMB efficace: Exemples d'essais cliniques « à risque »
Author keywords

[No Author keywords available]
Indexed keywords

DATA ANALYSIS; DATA SAFETY AND MONITORING BOARD; EXPERIENCE; HIGH RISK POPULATION; ILLNESS BEHAVIOR; MONITORING; PATIENT MONITORING; POPULATION RESEARCH; REVIEW; RISK BENEFIT ANALYSIS; SAFETY;
EID: 13944282527     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2005212187     Document Type: Review
Times cited : (2)
References (8)
  • 1
    • 12344295869 scopus 로고    scopus 로고
    • Les DSMB. 1. Quel rôle, quelles responsabilités?
    • Brun-Buisson C. Les DSMB. 1. Quel rôle, quelles responsabilités? Med Sci (Paris) 2005; 1: 78-82
    • (2005) Med Sci (Paris) , vol.1 , pp. 78-82
    • Brun-Buisson, C.1
  • 2
    • 0034062541 scopus 로고    scopus 로고
    • Are institutional review boards effective in safeguarding patients in intensive care units?
    • Lemaire F, Brun-Buisson C. Are institutional review boards effective in safeguarding patients in intensive care units? Curr Opin Anaesthesiol 2000; 13: 195-201.
    • (2000) Curr Opin Anaesthesiol , vol.13 , pp. 195-201
    • Lemaire, F.1    Brun-Buisson, C.2
  • 4
    • 0032517486 scopus 로고    scopus 로고
    • Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis
    • Wolkenstein P, Latarjet J, Roujeau JC, et al. Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet 1998; 352: 1586-9.
    • (1998) Lancet , vol.352 , pp. 1586-1589
    • Wolkenstein, P.1    Latarjet, J.2    Roujeau, J.C.3
  • 5
    • 2342502025 scopus 로고    scopus 로고
    • A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis
    • Naveau S, Chollet-Martin S, Dharancy S, et al. A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis. Hepatology 2004; 39: 1390-7.
    • (2004) Hepatology , vol.39 , pp. 1390-1397
    • Naveau, S.1    Chollet-Martin, S.2    Dharancy, S.3
  • 6
    • 0033539018 scopus 로고    scopus 로고
    • Increased mortality associated with growth hormone treatment in critically ill adults
    • Takala J, Ruokonen E, Webster NR, et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999; 341: 785-92.
    • (1999) N Engl J Med , vol.341 , pp. 785-792
    • Takala, J.1    Ruokonen, E.2    Webster, N.R.3
  • 7
    • 9144220131 scopus 로고    scopus 로고
    • Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: Results of a randomized, double-bund, placebo-controlled multicenter study (study n° 144-002)
    • Bakker J, Grover R, McLuckie A, et al. Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-bund, placebo-controlled multicenter study (study n° 144-002). Crit Care Med 2004; 32: 1-12.
    • (2004) Crit Care Med , vol.32 , pp. 1-12
    • Bakker, J.1    Grover, R.2    McLuckie, A.3
  • 8
    • 4444273012 scopus 로고    scopus 로고
    • Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock
    • Lopez A, Lorente JA, Steingrub J, et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 2004; 32: 21-30.
    • (2004) Crit Care Med , vol.32 , pp. 21-30
    • Lopez, A.1    Lorente, J.A.2    Steingrub, J.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.